humanized antibodies – image credits Wikipedia

 
NOVEMBER 2015 – Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemmorrhage, or severe trauma following an automobile accident, there is a

NOVEMBER 2015 – Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March

 

NOVEMBER 2015 – Additional lawsuits filed this year in Ohio and Pennsylvania allege that the blood thinner drug Xarelto is causing serious injuries and death to patients nationwide. Xarelto has been proven to cause complications, such as: excessive bleeding, red or black stools, frequent nosebleeds, pink or brown urine, unexplained bruises, bruises that increase

 

NOVEMBER 2015 – Numerous IVC filter lawsuits have been centralized for pretrial proceedings before Arizona U.S. District Judge David G. Campbell. Patients are experiencing serious health injuries when the filters are breaking apart and piercing their hearts. In many cases, all of the sharp metal fragments of the faulty filters are not recoverable, leaving